Vitreous humor is the clear, gel-like substance that fills roughly 80 percent of the eye’s interior, sitting between the lens at the front and the retina at the back. It is mostly water, but a sparse scaffold of collagen fibers and sugar-protein molecules called proteoglycans gives it a semisolid consistency that holds the eye’s shape, cushions delicate internal tissues, and keeps the light path to the retina unobstructed. Far from being an inert filler, the vitreous plays active roles in protecting the lens from oxygen damage, absorbing mechanical shocks, and even serving as a drug-delivery medium for modern therapies. It also changes dramatically over a lifetime, and those changes are behind some of the most common reasons people visit a retina specialist.
What the Vitreous Is Made Of
About 98 to 99 percent of vitreous humor is water. The remainder is a dilute network of type II collagen fibrils interwoven with hyaluronic acid, a large molecule that traps water and gives the gel its volume. Scattered proteoglycans help space the collagen fibers apart at regular intervals, which is essential for transparency: when collagen fibers are evenly distributed and much thinner than a wavelength of visible light, they scatter almost no light at all. The moment that spacing is disrupted, whether by aging, inflammation, or trauma, clumps of collagen become visible as shadows on the retina.
Imaging techniques have revealed that the vitreous is not a featureless blob. It contains identifiable internal structures, including a central channel (Cloquet’s canal, a remnant of embryonic blood supply), pockets of liquid vitreous near the back surface, and fissures running alongside retinal blood vessels.1PubMed. A journey through the world of vitreous These structures were once thought to be artifacts, but advanced imaging has confirmed they are real anatomical features that influence how the gel behaves in health and disease.
How the Vitreous Protects the Eye
The vitreous serves as a mechanical damper, absorbing impacts and protecting both the lens and the retina from sudden jolts.2PubMed Central. Rheological Properties and Age-Related Changes of the Human Vitreous Humor Its behavior is viscoelastic, meaning it acts partly like a solid and partly like a liquid depending on how fast the force is applied. During slow, gentle eye movements, the vitreous moves almost as a single mass. During sudden accelerations, like a fall or a collision, its viscous properties kick in and it resists rapid shearing. That resistance is what keeps the retina from tearing off the back wall of the eye during everyday bumps and jolts.3Optics and Lasers in Engineering. OCT-based dynamic mechanical analysis of vitreous humour When this damping function is compromised, as happens with age-related liquefaction, the risk of vitreous and even retinal detachment rises.
Less obviously, the vitreous also functions as a chemical shield for the lens. Ascorbate (vitamin C) dissolved in the gel reacts with oxygen, consuming it before it can reach the lens surface. The intact gel state preserves ascorbate levels and sustains this oxygen-scavenging reaction. When the gel breaks down or is surgically removed, the lens is exposed to substantially more oxygen, which promotes oxidative damage and accelerates the development of nuclear cataracts.4PubMed Central. The Gel State of the Vitreous and Ascorbate-Dependent Oxygen Consumption: Relationship to the Etiology of Nuclear Cataracts Computational modeling confirms this: losing the antioxidant capacity of ascorbate increases oxygen levels at the lens surface roughly threefold.5PubMed Central. Computational model for oxygen transport and consumption in human vitreous This is one reason eye surgeons think carefully before removing vitreous and why cataract progression after vitrectomy is a well-recognized side effect.
What Happens to the Vitreous as You Age
The vitreous does not stay the same your whole life. Beginning as early as your twenties, the gel starts to liquefy. Collagen fibers gradually fragment and clump together, while the proteoglycans that once held them in place aggregate around the broken fragments.6PubMed. Age-related liquefaction of the human vitreous body: LM and TEM evaluation of the role of proteoglycans and collagen What was once a uniform gel develops pockets of liquid interspersed with denser strands of collapsed collagen. This process is completely normal, but it has two familiar consequences: floaters and posterior vitreous detachment.
Floaters are the drifting specks, threads, or cobweb-like shapes people see against bright backgrounds. They are shadows cast by clumps of collagen or other debris suspended in the liquefying vitreous. For most people, floaters are a minor annoyance. But in a subset of patients, the accumulated debris degrades contrast sensitivity enough to genuinely impair daily vision, a condition sometimes called vision-degrading myodesopsia. A study of over 650 eyes found a clear correlation between the density of vitreous opacities and worsened contrast sensitivity.7PubMed Central. Clinical Management of Vision Degrading Myodesopsia from Vitreous Floaters – Observation vs. Limited Refractive Vitrectomy This is more than just seeing spots; people with significant floaters report reduced quality of life and trouble with tasks like reading and driving.8PubMed Central. Vitreous Floaters Functional Questionnaire for Vision-Degrading Myodesopsia From Vitreous Floaters
Posterior vitreous detachment (PVD) is the other major age-related event. As the vitreous shrinks and pulls away from the retina, the back face of the gel peels off like a sticker. Imaging shows this process begins in the region surrounding the fovea (the center of sharp vision) and progresses slowly, sometimes over months to years.9American Journal of Ophthalmology. Posterior Vitreous Detachment: Evolution and Complications of Its Early Stages Most PVDs are harmless, though the sudden onset of new floaters or flashes of light should prompt an urgent eye exam because the pulling vitreous can occasionally tear the retina on its way off.
When Vitreous Changes Cause Real Trouble
Not every PVD goes smoothly. When the vitreous liquefies faster than it releases from the retinal surface, the result is an abnormal or “anomalous” detachment. Where the vitreous is stuck tightest determines what goes wrong. At the edges of the retina, a stubborn attachment can rip the tissue, leading to retinal tears and, if untreated, retinal detachment. In the center of the retina, the same traction can drag on the macula, causing a condition called vitreomacular traction syndrome, or it can punch a full-thickness macular hole. Near the optic nerve, persistent pulling can worsen neovascularization, the abnormal new blood-vessel growth seen in diseases like diabetic retinopathy.10PubMed. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease
Bleeding into the vitreous cavity, known as vitreous hemorrhage, is another serious problem. The vitreous itself has no blood vessels, so any blood found in it comes from somewhere else: torn retinal vessels, abnormal new vessels from proliferative diabetic retinopathy, or trauma. The blood clouds the normally transparent gel and can drastically reduce vision.11PubMed Central. Vitreous hemorrhage – Causes, diagnosis, and management In diabetic patients, intravitreal injections of bevacizumab (an anti-VEGF drug) cleared the hemorrhage within three months in about 92 percent of cases, compared to 61 percent with other approaches, and the median time to clearance was roughly 46 days versus 70 days.12BMJ Open. Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy When bleeding is severe or persistent, surgical removal of the vitreous (vitrectomy) may be necessary.
Surgery Inside the Vitreous
Vitrectomy, the surgical removal of vitreous gel, is one of the most commonly performed retinal surgeries. After the gel is removed, the surgeon replaces it with a temporary filler to hold the retina in place while it heals. The two main options are gas bubbles (which the body gradually reabsorbs) and silicone oil (which stays in place until surgically removed). For uncomplicated retinal detachments, a meta-analysis found that both approaches reattach the retina at similar rates, around 88 to 90 percent. But patients who received gas tamponade ended up with better final visual acuity and thicker retinal nerve layers, suggesting that silicone oil, while effective at reattachment, may carry a subtle long-term cost to retinal health.13PubMed. A journey through the world of vitreous This is an active area of debate among surgeons, and the choice often depends on how complicated the detachment is and whether the patient can maintain a specific head position (gas bubbles require positioning; silicone oil does not).
For vitreomacular traction and small macular holes, a less invasive option emerged with ocriplasmin, an enzyme injected directly into the vitreous. Rather than surgically cutting the gel away, ocriplasmin dissolves specific proteins at the vitreous-retina interface, encouraging the gel to release on its own. In pivotal trials, a single injection resolved the abnormal vitreous-retinal adhesion in about 27 percent of treated eyes, versus 10 percent with a sham injection. For macular holes specifically, nonsurgical closure occurred in about 41 percent of treated eyes compared to roughly 11 percent with placebo.14PubMed. Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes Those success rates are modest, and not every patient is a good candidate, but the option of an injection instead of surgery is significant for people with early or mild disease.15PubMed Central. Ocriplasmin: who is the best candidate?
The Vitreous as a Drug-Delivery Space
One of the most rapidly growing areas in ophthalmology is intravitreal drug delivery, the injection of medications directly into the vitreous cavity. Anti-VEGF drugs for wet age-related macular degeneration and diabetic eye disease are the most prominent example, and millions of these injections are administered worldwide every year. The vitreous acts as a reservoir: the injected drug diffuses through the gel and is gradually eliminated, mainly through the front of the eye via the outflow of aqueous humor. Drug concentrations in the vitreous can remain roughly ten times higher than in the aqueous humor, which helps maintain therapeutic levels at the retina.16PubMed Central. Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments
How quickly a drug clears from the vitreous depends on its size and charge. Larger molecules like antibodies (bevacizumab, ranibizumab, aflibercept) linger longer than small molecules, which is partly why anti-VEGF treatments can be given every four to eight weeks rather than daily. A drug’s molecular weight and charge also determine how it distributes within the gel, which matters for whether it reaches the retina at effective concentrations.17PubMed Central. Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration Changes to the vitreous itself, including liquefaction and prior vitrectomy, alter these pharmacokinetics. A liquefied or absent vitreous means drugs move more freely and clear faster, potentially requiring more frequent dosing.
How the Vitreous Develops Before Birth
The vitreous you have as an adult is not the vitreous you started with. During embryonic development, the eye first fills with a “primary vitreous” that is rich in blood vessels, feeding the growing lens and retina. As the eye matures, this vascular scaffolding is replaced by a “secondary vitreous” that is avascular, the clear gel we recognize in the adult eye. Cloquet’s canal, the tubular passage running from the optic nerve to the back of the lens, is a remnant of the main vessel (the hyaloid artery) that once ran through the primary vitreous.18PubMed. Remodelling of the human vitreous and vitreoretinal interface–a dynamic process In rare cases, parts of this embryonic vascular system fail to regress completely, leading to a congenital condition called persistent hyperplastic primary vitreous (now more commonly termed persistent fetal vasculature). Affected infants may present with a white pupil, a smaller-than-normal eye, or developmental cataracts, and the condition often requires surgical management.
Forensic Uses of Vitreous Humor
Outside the clinic, vitreous humor has a surprising role in forensic science. After death, the vitreous is one of the most useful biological fluids an investigator can sample. It sits inside a sealed compartment, shielded from contamination by gut bacteria and from the chemical chaos of decomposition that rapidly alters blood. Collecting it is simple: a needle through the eyeball withdraws a milliliter or two of fluid that can be analyzed for drugs, metabolites, and electrolytes.19PubMed Central. Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review
Forensic toxicologists favor vitreous for drug analysis because it is far less susceptible to postmortem redistribution, the phenomenon where drugs leak out of tissues into the blood after death and produce misleadingly high or low concentrations. If a blood sample shows an unexpectedly high drug level, a vitreous sample can help confirm whether that level was real or an artifact of decomposition. Most drugs that circulate in the bloodstream eventually cross the blood-retinal barrier and appear in vitreous fluid, making it a reliable backup matrix for toxicology screens.
The other major forensic application is estimating the time since death. Potassium ions leak out of cells into the vitreous at a roughly predictable rate after death, and measuring potassium concentration has been used for decades as a postmortem interval indicator. In practice, though, accuracy has been a persistent problem. A large pilot study of over 1,400 cases found that the 95 percent prediction interval for time since death was approximately plus or minus 20 hours, and the regression explained only about 37 percent of the variation in potassium levels.20Journal of Forensic Sciences. Vitreous Humor Chemistry: The Use of Potassium Concentration for the Prediction of the Postmortem Interval That is a wide margin of error. Researchers continue working on more sophisticated approaches, including multivariate models that combine several ion concentrations and even genomic sequencing of the microbial communities that colonize vitreous fluid after death.21PubMed Central. Review of Postmortem Interval Estimation Using Vitreous Humor: Past, Present, and Future
The Vitreous as a Diagnostic Window
Proteomics, the large-scale study of proteins, has revealed that the vitreous is far more biologically active than researchers once assumed. Rather than being a passive gel, the vitreous contains a complex protein landscape that shifts in response to retinal disease. Studies have identified hundreds of quantifiable proteins in vitreous samples, and the protein profiles differ distinctly between diseases. A comparative analysis of vitreous from patients with diabetic retinopathy, retinal detachment, and a benign control condition identified over 200 differentially expressed proteins in retinal detachment alone and highlighted glucose metabolism as a pathway altered in both diabetic and non-diabetic retinal diseases.22PubMed Central. Comparative proteomic analysis of human vitreous in rhegmatogenous retinal detachment and diabetic retinopathy reveals a common pathway and potential therapeutic target
The practical implication is that the vitreous could eventually serve as a liquid biopsy for the retina. Changes in the vitreous proteome reflect not just what the vitreous itself is doing but also what is happening in the adjacent retinal tissue, which is otherwise very difficult to sample without damaging it.23PubMed Central. Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases This line of research is still in its early stages, but the prospect of identifying disease-specific protein signatures in vitreous fluid collected during routine surgery could eventually help clinicians tailor treatments more precisely.
Building an Artificial Vitreous
When the vitreous is removed during surgery, nothing currently replaces it permanently in a way that replicates all its original functions. Gas bubbles and silicone oil are temporary tamponade agents, not true vitreous substitutes. Saline solution, which is sometimes used after vitrectomy, fills the space but has none of the gel’s shock-absorbing, oxygen-regulating, or drug-retaining properties. This gap has driven a growing field of research into synthetic vitreous substitutes, primarily based on hydrogels.
Hydrogels are water-swollen polymer networks that can be tuned to mimic the transparency, refractive index, and viscoelastic behavior of natural vitreous. Researchers are experimenting with both natural polymers like hyaluronic acid and collagen (the building blocks of the real thing) and synthetic polymers like polyethylene glycol and polyvinyl alcohol, which offer more control over mechanical properties.24PubMed Central. Hydrogel-Based Vitreous Substitutes The challenge is formidable: the ideal substitute would need to be optically clear, biocompatible over years, gel-like enough to dampen shocks, and stable enough not to break down or shift in shape. It would also ideally maintain the oxygen-consuming environment that protects the lens.
A more ambitious approach aims not just to fill the space but to trigger the eye to rebuild its own vitreous. One research group has developed a thermogel, a material that is liquid at room temperature but gels at body temperature, that gradually degrades inside the eye. As it breaks down, it appears to stimulate the formation of a new vitreous-like body in the cavity.25ACS Materials Letters. Hydrogels for Artificial Vitreous: From Prolonged Substitution to Elicited Regeneration Whether this regenerative approach can work reliably in human eyes remains to be seen, but it represents a conceptual shift from passive replacement to active tissue engineering. Given how many complications stem from vitreous loss or degradation, from cataracts to altered drug clearance to impaired shock absorption, a functional permanent substitute would have far-reaching benefits for patients who undergo vitrectomy.